SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-18-018374
Filing Date
2018-06-27
Accepted
2018-06-27 17:59:11
Documents
2
Period of Report
2018-06-27

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 8571
2 EX-24 DOCUMENT attachment1.htm EX-24 4499
  Complete submission text file 0000899243-18-018374.txt   14536
Mailing Address 29 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 29 HARTWELL AVENUE LEXINGTON MA 02421 617-945-7361
Translate Bio, Inc. (Issuer) CIK: 0001693415 (see all company filings)

IRS No.: 611807780 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O AILERON THERAPEUTICS, INC. 281 ALBANY STREET CAMBRIDGE MA 02139
Business Address
Gallagher Brian M. Jr. (Reporting) CIK: 0001709976 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38550 | Film No.: 18922697